Detalles de la búsqueda
1.
Glycaemic control efficacy of switching from dipeptidyl peptidase-4 inhibitors to oral semaglutide in subjects with type 2 diabetes: A multicentre, prospective, randomized, open-label, parallel-group comparison study (SWITCH-SEMA 2 study).
Diabetes Obes Metab;
26(3): 961-970, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38073422
2.
Positive association between the proinsulin-to-C-peptide ratio and prolonged hyperglycemic time in type 2 diabetes.
Endocr J;
71(4): 403-408, 2024 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38403638
3.
Positive association between proinsulin and fatty liver index in people with type 2 diabetes.
Endocr J;
71(2): 193-197, 2024 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38123335
4.
Real-world clinical evidence of oral semaglutide on metabolic abnormalities in subjects with type 2 diabetes: a multicenter retrospective observational study (the Sapporo-Oral SEMA study).
Endocr J;
2024 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38658349
5.
Inverse association between glucose variability and body fat in type 2 diabetes with impaired endogenous insulin secretion assessed using continuous glucose monitoring: A prospective observational study.
Diabetes Obes Metab;
25(7): 1883-1889, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36906821
6.
Improvement of glycaemic control and treatment satisfaction by switching from liraglutide or dulaglutide to subcutaneous semaglutide in patients with type 2 diabetes: A multicentre, prospective, randomized, open-label, parallel-group comparison study (SWITCH-SEMA 1 study).
Diabetes Obes Metab;
25(6): 1503-1511, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36722623
7.
Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas.
Pituitary;
26(5): 597-610, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37642928
8.
Glucokinase activation leads to an unsustained hypoglycaemic effect with hepatic triglyceride accumulation in db/db mice.
Diabetes Obes Metab;
24(3): 391-401, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34704329
9.
Impact of low-starch high-fiber pasta on postprandial blood glucose.
Nutr Metab Cardiovasc Dis;
32(2): 487-493, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34893415
10.
Lymphocytic panhypophysitis and anti-rabphilin-3A antibody with pulmonary sarcoidosis.
Pituitary;
25(2): 321-327, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35088194
11.
Do the benefits of sodium-glucose cotransporter 2 inhibitors exceed the risks in patients with type 1 diabetes?
Endocr J;
69(5): 495-509, 2022 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34819409
12.
Severe infection including disseminated herpes zoster triggered by subclinical Cushing's disease: a case report.
BMC Endocr Disord;
21(1): 84, 2021 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33906651
13.
Silent pituitary adenoma and metabolic disorders: obesity, abnormal glucose tolerance, hypertension and dyslipidemia.
Endocr J;
68(2): 195-200, 2021 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33028757
14.
Successful management of a patient with active Cushing's disease complicated with coronavirus disease 2019 (COVID-19) pneumonia.
Endocr J;
68(4): 477-484, 2021 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33361650
15.
Incidence and risk of antiresorptive agent-related osteonecrosis of the jaw (ARONJ) after tooth extraction in patients with autoimmune disease.
J Bone Miner Metab;
38(4): 581-588, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32076874
16.
A comparative study of the effects of imeglimin add-on or metformin dose escalation on glycaemic variability in subjects with type 2 diabetes treated with low-dose metformin (MEGMI-CGM study).
Diabetes Obes Metab;
2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38699794
17.
Nivolumab-induced hypophysitis causing secondary adrenal insufficiency after transient ACTH elevation.
Endocr J;
66(10): 937-941, 2019 Oct 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-31217401
18.
FGFR1 Analyses in Four Patients with Hypogonadotropic Hypogonadism with Split-Hand/Foot Malformation: Implications for the Promoter Region.
Hum Mutat;
38(5): 503-506, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28087897
19.
Effects of 50 mg vildagliptin twice daily vs. 50 mg sitagliptin once daily on blood glucose fluctuations evaluated by long-term self-monitoring of blood glucose.
Endocr J;
64(4): 417-424, 2017 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-28260702
20.
Factors associated with an inadequate hypoglycemia in the insulin tolerance test in Japanese patients with suspected or proven hypopituitarism.
Endocr J;
64(4): 387-392, 2017 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-28260701